APYX MEDICAL CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.45 USD | -2.03% |
|
+9.85% | -44.66% |
| 04-05 | Archon Capital Management Engages with Apyx Medical Corporation | CI |
| 04-01 | Stavros G. Vizirgianakis Engages in Discussions with Apyx Medical Corporation | CI |
Chart calendar Apyx Medical Corporation
7d2.whXMP-vFk6vUxMK6-gA5YRdcwRh5CxdBz_Fq2MFJokU.lmCYcpuS0cKxh4jYm00AEH4WlyArck0Fg8ABjbsYxxS1JYFKhqql7I6uhw~3b44ff4bc33e464fd8c1cf7334950dfc
Upcoming events on Apyx Medical Corporation
Past events on Apyx Medical Corporation
| 21/03/2024 12:00 | Q4 2023 Earnings Call |
| 21/03/2024 11:00 | Q4 2023 Earnings Release |
| 24/02/2024 18:30 | American Academy of Cosmetic Surgery Scientific Meeting |
| 24/02/2024 16:00 | American Academy of Cosmetic Surgery Scientific Meeting |
| 22/02/2024 21:00 | American Academy of Cosmetic Surgery Scientific Meeting |
| 29/11/2023 21:00 | Piper Sandler Healthcare Conference |
| 15/11/2023 | Craig-Hallum Alpha Select Conference |
| 14/11/2023 17:00 | Stephens Investment Conference |
| 09/11/2023 13:00 | Q3 2023 Earnings Call |
| 09/11/2023 12:00 | Q3 2023 Earnings Release |
| 10/08/2023 22:00 | Q2 2023 Earnings Call |
| 10/08/2023 21:05 | Q2 2023 Earnings Release |
| 10/08/2023 14:00 | Annual General Meeting |
| 11/05/2023 13:00 | Q1 2023 Earnings Call |
| 11/05/2023 12:00 | Q1 2023 Earnings Release |
| 16/03/2023 12:00 | Q4 2022 Earnings Call |
| 16/03/2023 11:00 | Q4 2022 Earnings Release |
| 30/11/2022 16:00 | Piper Sandler Healthcare Conference |
| 10/11/2022 13:00 | Q3 2022 Earnings Call |
| 10/11/2022 12:00 | Q3 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 28,2 27,7 1.59% | 27,7 26,5 4.57% | 48,5 48,0 0.97% | 44,5 44,9 -0.96% | 52,3 52,0 0.71% | 49,9 |
|
EBITDA Million USD | Released Forecast Spread | -17,0 -17,0 0.26% | -14,5 -16,1 10.01% | -8,80 -10,5 15.8% | -15,4 -14,2 -8.23% | -13,4 -12,9 -4.13% | -17,3 |
|
EBIT Million USD | Released Forecast Spread | -20,9 -21,3 1.76% | -20,1 -21,6 7.18% | -14,4 -16,1 10.26% | -23,6 -22,6 -4.32% | -17,3 -14,8 -16.43% | -22,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -19,9 -19,9 -0.15% | -19,4 -21,1 8.23% | -14,8 -16,4 9.46% | -22,9 -21,9 -4.55% | -21,3 -18,0 -17.92% | -27,3 |
|
Net income Million USD | Released Forecast Spread | -19,7 -19,9 1.11% | -11,9 -13,9 14.47% | -15,2 -16,6 8.73% | -23,2 -22,2 -4.55% | -18,7 -15,4 -21.4% | -27,7 |
|
EPS USD | Released Forecast Spread | -0,58 -0,60 2.79% | -0,35 -0,41 15.15% | -0,44 -0,50 11.11% | -0,67 -0,64 -4.28% | -0,54 -0,45 -20% | -0,78 |
| Announcement Date | 16/03/20 | 31/03/21 | 17/03/22 | 16/03/23 | 21/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 16,8 16,4 2.88% | 12,5 11,1 12.33% | 10,3 10,6 -2.51% | 9,11 12,0 -24.11% | 12,6 13,0 -3.3% | 12,1 10,8 12.06% | 13,6 14,3 -5.28% | 12,0 15,4 -22.08% | 14,7 14,3 2.64% | 9,53 | 12,2 | 12,2 | 16,0 | 10,6 |
|
EBITDA Million USD | Released Forecast Spread | -0,30 -1,95 84.59% | -3,99 -3,67 -8.7% | -3,38 -4,69 27.9% | -3,88 -3,09 -25.52% | -4,12 -2,93 -40.35% | -4,00 -4,43 9.74% | -1,62 -2,23 27.11% | -3,07 -1,85 -66.49% | -4,69 -4,16 -12.83% | -5,41 | -4,36 | -4,50 | -3,07 | -2,97 |
|
EBIT Million USD | Released Forecast Spread | -1,69 -3,34 49.41% | -5,87 -5,31 -10.65% | -5,98 -6,63 9.86% | -5,78 -5,01 -15.42% | -5,93 -4,93 -20.24% | -5,61 -4,87 -15.29% | -1,24 -4,02 69.28% | -4,64 -3,27 -41.79% | -5,78 -3,34 -73.19% | -6,72 | -5,69 | -5,86 | -4,55 | -4,56 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -1,88 -3,43 45.23% | -5,90 -5,16 -14.22% | -5,35 -6,66 19.59% | -5,75 -4,73 -21.41% | -5,91 -4,92 -20.3% | -5,80 -5,13 -13.06% | -0,95 -2,67 64.35% | -4,99 -3,92 -27.47% | -9,54 -6,28 -51.75% | -7,84 | -6,82 | -7,00 | -5,69 | -5,41 |
|
Net income Million USD | Released Forecast Spread | -2,00 -3,51 42.89% | -5,95 -5,26 -13.08% | -5,43 -6,60 17.77% | -5,76 -5,08 -13.44% | -6,05 -5,03 -20.36% | -3,48 -4,67 25.4% | -0,99 -2,48 59.84% | -4,63 -3,93 -17.71% | -9,61 -6,27 -53.21% | -7,94 | -6,90 | -7,08 | -5,78 | -5,47 |
|
EPS USD | Released Forecast Spread | -0,06 -0,11 45.45% | -0,17 -0,15 -15.91% | -0,16 -0,19 14.67% | -0,17 -0,15 -17.24% | -0,17 -0,15 -17.24% | -0,10 -0,14 25.93% | -0,03 -0,07 57.14% | -0,13 -0,11 -14.04% | -0,28 -0,19 -51.35% | -0,22 | -0,20 | -0,20 | -0,17 | -0,15 |
| Announcement Date | 17/03/22 | 12/05/22 | 11/08/22 | 10/11/22 | 16/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 21/03/24 | - | - | - | - | - |
More events
Past sector events for Apyx Medical Corporation
| 26/04/2024 | BLUE SAIL MEDICAL CO.,LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | BLUE SAIL MEDICAL CO.,LTD.: Q4 2023 Earnings Release |
| 26/04/2024 11:00 | AVANTOR, INC.: Q1 2024 Earnings Release |
| 25/04/2024 | MOTIC (XIAMEN) ELECTRIC GROUP CO.,LTD: Q1 2024 Earnings Release |
| 25/04/2024 | MICRO-TECH (NANJING) CO.,LTD: Q1 2024 Earnings Release |
| 25/04/2024 | SINOCARE INC.: Q4 2023 Earnings Release |
| 25/04/2024 | JAFRON BIOMEDICAL CO.,LTD.: Q1 2024 Earnings Release |
| 25/04/2024 | MICRO-TECH (NANJING) CO.,LTD: Q4 2023 Earnings Release |
| 25/04/2024 | JAFRON BIOMEDICAL CO.,LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | SINOCARE INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- APYX Stock
- Calendar Apyx Medical Corporation
